Lightning Talks featuring startups: Enbiotix, Ginkgo Bioworks, ManusBio, Glympse Bio, BioDevek, Asimov, and BioBuilder.
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Matthew Decker
Global Technical Leader - Comfort and Biophysics Group,W.L. Gore & Associates
Rana el Kaliouby, CEO & Cofounder, Affectiva
Procter & Gamble is looking for new approaches and technologies that can help them to address key business challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
Synthetic Biology Workshop 2017 - Panel Discussion
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
JC Gutiérrez-Ramos, President and CEO, Synlogic
Nan-Wei Gong, Cofounder & CEO, figur8